Mechanisms of induction of cell cycle arrest and cell death by cryptolepine in human lung adenocarcinoma a549 cells

Toxicological Sciences : an Official Journal of the Society of Toxicology
Huijun Zhu, Nigel J Gooderham

Abstract

We investigated p53-dependent and -independent molecular events associated with cell cycle alteration and cell death in human lung adenocarcinoma A549 cells using cryptolepine, a DNA-damaging agent. After a 24-h treatment, cryptolepine caused an accumulation of p53 at concentrations of 1.25-10 microM and induction of p21(Cip1/WAF1) but only at concentrations up to 5muM. p21(Cip1/WAF1) was also strongly induced by cryptolepine (2.5-5 microM) in cells with p53 largely ablated via small interfering RNA-mediated gene silencing. Cryptolepine induced G1-phase block at 1.25-2.5 microM, S-phase and G2/M-phase block at 2.5-5 microM, and cell death at 10 microM. The dead cells displayed condensed and fragmented nuclei, features of apoptosis. Wortmannin, an inhibitor of ataxia telangiectasia-mutated and DNA-dependent protein kinase (DNA-PK), caused cell cycle arrest at G1 phase without inducing p53 and p21(Cip1/WAF1) expression and cell death. The addition of wortmannin partially prevented cryptolepine-induced expression of p53 and p21(Cip1/WAF1) together with the S-phase block and sensitized cells to induction of cell death. NU7026, a DNA-PK-specific inhibitor, showed neither induction of cell cycle arrest and apoptosis nor the expressio...Continue Reading

References

Apr 1, 1992·Nature Genetics·W S el-DeiryB Vogelstein
Jan 1, 1992·Cytometry·Z DarzynkiewiczF Traganos
Jun 1, 1992·Molecular and Cellular Biology·W D FunkJ W Shay
Nov 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·D GinsbergM Oren
Dec 16, 1993·Nature·Y XiongD Beach
Nov 1, 1996·Molecular and Cellular Biology·J H Ludes-MeyersS Deb
Aug 1, 1997·Current Biology : CB·S E CritchlowS P Jackson
Jan 30, 1999·Genes & Development·R S TibbettsR T Abraham
May 11, 2000·Molecular and Cellular Biology·C JhappanG Merlino
Sep 6, 2000·Proceedings of the National Academy of Sciences of the United States of America·S MatsuokaS J Elledge
Oct 5, 2002·Cellular and Molecular Life Sciences : CMLS·C H YamR Y C Poon
Nov 21, 2002·Toxicological Sciences : an Official Journal of the Society of Toxicology·Charles Ansah, Nigel J Gooderham
Apr 2, 2003·Molecular Cell·Motohiro MiharaUte M Moll
Aug 2, 2003·Biochemical and Biophysical Research Communications·Shuo RenNobuo Tsuchida
Jun 24, 2004·Progress in Nucleic Acid Research and Molecular Biology·Jerzy Majka, Peter M J Burgers
Jan 26, 2005·The Journal of Biological Chemistry·Jia Li, David F Stern
Mar 1, 2005·Trends in Genetics : TIG·Martin Schuler, Douglas R Green
May 13, 2005·Carcinogenesis·Karen S Yee, Karen H Vousden
Jun 15, 2005·Annual Review of Biochemistry·Aaron Johnson, Mike O'Donnell
Dec 1, 2005·Molecular Cancer Research : MCR·Cécile-Marie Aliouat-DenisJorge E Vialard

❮ Previous
Next ❯

Citations

Jun 1, 2007·Expert Opinion on Drug Discovery·Norman S Radin
Jun 24, 2014·The International Journal of Biochemistry & Cell Biology·Elzbieta PastwaRichard I Somiari
Nov 23, 2013·European Journal of Medicinal Chemistry·Baljinder SinghRam A Vishwakarma
Jun 14, 2016·Canadian Journal of Physiology and Pharmacology·Ying-Hua HeJun Li
Dec 24, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Harish C Pal, Santosh K Katiyar
Feb 18, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Zeina HabliHala Gali-Muhtasib
Mar 20, 2010·Organic & Biomolecular Chemistry·Christophe LarocheSean M Kerwin
Apr 3, 2019·Journal of Enzyme Inhibition and Medicinal Chemistry·Jana JanockovaMaria Kozurkova
Aug 9, 2018·Molecular Biology Reports·Angelika DługoszAnna Janecka
Oct 30, 2012·Acta Medica (Hradec Králové)·Ales TichýMartina Rezácová
Jan 1, 2017·Advances in Pharmacological Sciences·Newman OsafoOduro Kofi Yeboah
Jun 4, 2021·BMC Complementary Medicine and Therapies·Seth A DomfehMohamed Mutocheluh
Jun 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Katja S HåheimMagne O Sydnes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.